STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
70 hedge funds and large institutions have $338M invested in Stemline Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
70
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14M | |
| 2 | +$7.93M | |
| 3 | +$7.09M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$7.09M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.88M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$6.79M | |
| 3 | -$5.43M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$4.51M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.44M |